FRONTLINE THERAPY OF CHRONIC MYELOID LEUKEMIA (CML)

被引:0
|
作者
Kantarjian, Hagop [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
10.1016/S0145-2126(14)70007-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
SP-001
引用
收藏
页码:S1 / S1
页数:1
相关论文
共 50 条
  • [21] Chronic myeloid leukemia (CML) diagnosis in 2012
    Cayuela, J. -M.
    Huguet, F.
    ONCOLOGIE, 2012, 14 (10-11) : 561 - 568
  • [22] Expert Seminar on "Chronic Myeloid Leukemia (CML)"
    Koschmieder, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 223 - 223
  • [23] Symptom burden in chronic myeloid leukemia (CML).
    Williams, L. A.
    Ault, P.
    Cleeland, C. S.
    Reynolds, R. J.
    Shah, N. A.
    Shah, P. K.
    Cortes, J. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] Prognostic Factors in Chronic Myeloid Leukemia (CML)
    Hochhaus, Andreas
    ONKOLOGIE, 2008, 31 (11): : 576 - 578
  • [25] Molecular monitoring in chronic myeloid leukemia (CML)
    Izzo, Barbara
    Accetta, Raffaella
    Caruso, Simona
    De Angelis, Biagio
    Del Prete, Ciro
    Errichiello, Santa
    Galdiero, Alessandra
    Casadei, Giada Muccioli
    Musella, Filomena
    Quintarelli, Concetta
    Visconti, Roberta
    Pane, Fabrizio
    BIOCHIMICA CLINICA, 2015, 39 (02) : 94 - 99
  • [26] Advances in Immunotherapy of Chronic Myeloid Leukemia CML
    Held, Stefanie Andrea Erika
    Heine, Annkristin
    Mayer, Karin Tina
    Kapelle, Mario
    Wolf, Dominik Georg Friedrich
    Brossart, Peter
    CURRENT CANCER DRUG TARGETS, 2013, 13 (07) : 768 - 774
  • [27] Molecular response of paediatric chronic myeloid leukemia (CML) with imatinib mesylate therapy
    Dhara, Atanu
    Mukhopadhyay, S.
    Das, S.
    Mukhopadhyay, A.
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 444 - 445
  • [28] Weight gain associated with imatinib therapy in patients with chronic myeloid leukemia (CML).
    Ault, P
    Kantarjian, H
    Kaled, S
    Rios, MB
    O'Brien, S
    Cortes, JE
    BLOOD, 2002, 100 (11) : 321B - 321B
  • [29] Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platform
    Valent, Peter
    Lion, Thomas
    Wolf, Dominik
    Sillaber, Christian
    Agis, Hermine
    Petzer, Andreas
    Lang, Alois
    Kalhs, Peter
    Geissler, Dietmar
    Greil, Richard
    Linkesch, Werner
    Burgstaller, Sonja
    Thaler, Josef
    Gastl, Gunther
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 (21-22) : 697 - 709
  • [30] Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party
    Gugliotta, Gabriele
    Castagnetti, Fausto
    Palandri, Francesca
    Breccia, Massimo
    Intermesoli, Tamara
    Capucci, Adele
    Martino, Bruno
    Pregno, Patrizia
    Rupoli, Serena
    Ferrero, Dario
    Gherlinzoni, Filippo
    Montefusco, Enrico
    Bocchia, Monica
    Tiribelli, Mario
    Pierri, Ivana
    Grifoni, Federica
    Marzocchi, Giulia
    Amabile, Marilina
    Testoni, Nicoletta
    Martinelli, Giovanni
    Alimena, Giuliana
    Pane, Fabrizio
    Saglio, Giuseppe
    Baccarani, Michele
    Rosti, Gianantonio
    BLOOD, 2011, 117 (21) : 5591 - 5599